Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Joseph Biederman, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Joseph Biederman and Ronna Fried.
Joseph Biederman
Connection Strength
12.930
Ronna Fried
  1. An innovative SMS intervention to improve adherence to stimulants in children with ADHD: Preliminary findings. J Psychopharmacol. 2020 08; 34(8):883-890.
    View in: PubMed
    Score: 0.885
  2. Can the CANTAB identify adults with attention-deficit/hyperactivity disorder? A controlled study. Appl Neuropsychol Adult. 2021 May-Jun; 28(3):318-327.
    View in: PubMed
    Score: 0.849
  3. Does Working Memory Impact Functional Outcomes in Individuals With ADHD: A Qualitative and Comprehensive Literature Review. J Atten Disord. 2019 11 01; 23(13):1592-1599.
    View in: PubMed
    Score: 0.747
  4. A study of the neuropsychological correlates in adults with high functioning autism spectrum disorders. Acta Neuropsychiatr. 2016 Oct; 28(5):286-95.
    View in: PubMed
    Score: 0.676
  5. Clinical correlates of working memory deficits in youth with and without ADHD: A controlled study. J Clin Exp Neuropsychol. 2016; 38(5):487-96.
    View in: PubMed
    Score: 0.671
  6. Is ADHD a Risk Factor for High School Dropout? A Controlled Study. J Atten Disord. 2016 May; 20(5):383-9.
    View in: PubMed
    Score: 0.543
  7. How Informative Is the CANTAB to Assess Executive Functioning in Children With ADHD? A Controlled Study. J Atten Disord. 2015 Jun; 19(6):468-75.
    View in: PubMed
    Score: 0.527
  8. A controlled study of a simulated workplace laboratory for adults with attention deficit hyperactivity disorder. Psychiatry Res. 2012 Dec 30; 200(2-3):949-56.
    View in: PubMed
    Score: 0.517
  9. Characterizing impaired driving in adults with attention-deficit/hyperactivity disorder: A controlled study. J Clin Psychiatry. 2006 Apr; 67(4):567-74.
    View in: PubMed
    Score: 0.338
  10. Further evidence of low adherence to stimulant treatment in adult ADHD: an electronic medical record study examining timely renewal of a stimulant prescription. Psychopharmacology (Berl). 2020 Sep; 237(9):2835-2843.
    View in: PubMed
    Score: 0.227
  11. A novel digital health intervention to improve patient engagement to stimulants in adult ADHD in the primary care setting: Preliminary findings from an open label study. Psychiatry Res. 2020 09; 291:113158.
    View in: PubMed
    Score: 0.226
  12. Toward operationalizing deficient emotional self-regulation in newly referred adults with ADHD: A receiver operator characteristic curve analysis. Eur Psychiatry. 2020 02 24; 63(1):e21.
    View in: PubMed
    Score: 0.221
  13. A literature review and meta-analysis on the effects of ADHD medications on functional outcomes. J Psychiatr Res. 2020 04; 123:21-30.
    View in: PubMed
    Score: 0.220
  14. A prospective open-label trial of long-acting liquid methylphenidate for the treatment of attention deficit/hyperactivity disorder in intellectually capable adults with autism spectrum disorder. World J Biol Psychiatry. 2020 04; 21(4):274-290.
    View in: PubMed
    Score: 0.219
  15. Predictive utility of autistic traits in youth with ADHD: a controlled 10-year longitudinal follow-up study. Eur Child Adolesc Psychiatry. 2020 Jun; 29(6):791-801.
    View in: PubMed
    Score: 0.214
  16. Quantifying the Protective Effects of Stimulants on Functional Outcomes in Attention-Deficit/Hyperactivity Disorder: A Focus on Number Needed to Treat Statistic and Sex Effects. J Adolesc Health. 2019 12; 65(6):784-789.
    View in: PubMed
    Score: 0.213
  17. A Novel Text Message Intervention to Improve Adherence to Stimulants in Adults With Attention Deficit/Hyperactivity Disorder. J Clin Psychopharmacol. 2019 Jul/Aug; 39(4):351-356.
    View in: PubMed
    Score: 0.212
  18. Evidence of Low Adherence to Stimulant Medication Among Children and Youths With ADHD: An Electronic Health Records Study. Psychiatr Serv. 2019 10 01; 70(10):874-880.
    View in: PubMed
    Score: 0.211
  19. Clinical correlates of mind wandering in adults with ADHD. J Psychiatr Res. 2019 10; 117:15-23.
    View in: PubMed
    Score: 0.211
  20. High Risk for Severe Emotional Dysregulation in Psychiatrically Referred Youth with Autism Spectrum Disorder: A Controlled Study. J Autism Dev Disord. 2018 Sep; 48(9):3101-3115.
    View in: PubMed
    Score: 0.200
  21. Towards operationalising internal distractibility (Mind Wandering) in adults with ADHD. Acta Neuropsychiatr. 2017 Dec; 29(6):330-336.
    View in: PubMed
    Score: 0.190
  22. Memantine in the Treatment of Executive Function Deficits in Adults With ADHD. J Atten Disord. 2017 02; 21(4):343-352.
    View in: PubMed
    Score: 0.173
  23. A Prospective Open-Label Trial of Memantine Hydrochloride for the Treatment of Social Deficits in Intellectually Capable Adults With Autism Spectrum Disorder. J Clin Psychopharmacol. 2016 Jun; 36(3):262-71.
    View in: PubMed
    Score: 0.171
  24. Examining the clinical correlates of autism spectrum disorder in youth by ascertainment source. J Autism Dev Disord. 2014 Sep; 44(9):2117-26.
    View in: PubMed
    Score: 0.151
  25. Symptom Profile of ADHD in Youth With High-Functioning Autism Spectrum Disorder: A Comparative Study in Psychiatrically Referred Populations. J Atten Disord. 2017 Aug; 21(10):846-855.
    View in: PubMed
    Score: 0.151
  26. Brief report: examining driving behavior in young adults with high functioning autism spectrum disorders: a pilot study using a driving simulation paradigm. J Autism Dev Disord. 2013 Sep; 43(9):2211-7.
    View in: PubMed
    Score: 0.141
  27. Autistic traits in children with and without ADHD. Pediatrics. 2013 Sep; 132(3):e612-22.
    View in: PubMed
    Score: 0.141
  28. Psychiatric comorbidity and functioning in a clinically referred population of adults with autism spectrum disorders: a comparative study. J Autism Dev Disord. 2013 Jun; 43(6):1314-25.
    View in: PubMed
    Score: 0.139
  29. Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHD. Child Neuropsychol. 2014; 20(3):319-27.
    View in: PubMed
    Score: 0.138
  30. An examination of the impact of attention-deficit hyperactivity disorder on IQ: a large controlled family-based analysis. Can J Psychiatry. 2012 Oct; 57(10):608-16.
    View in: PubMed
    Score: 0.133
  31. Is the diagnosis of ADHD influenced by time of entry to school? An examination of clinical, familial, and functional correlates in children at early and late entry points. J Atten Disord. 2014 Apr; 18(3):179-85.
    View in: PubMed
    Score: 0.129
  32. The effects of lisdexamfetamine dimesylate on driving behaviors in young adults with ADHD assessed with the Manchester driving behavior questionnaire. J Adolesc Health. 2012 Dec; 51(6):601-7.
    View in: PubMed
    Score: 0.129
  33. The effects of lisdexamfetamine dimesylate on the driving performance of young adults with ADHD: a randomized, double-blind, placebo-controlled study using a validated driving simulator paradigm. J Psychiatr Res. 2012 Apr; 46(4):484-91.
    View in: PubMed
    Score: 0.126
  34. Examining the association between stimulant treatment and cognitive outcomes across the life cycle of adults with attention-deficit/hyperactivity disorder: a controlled cross-sectional study. J Nerv Ment Dis. 2012 Jan; 200(1):69-75.
    View in: PubMed
    Score: 0.126
  35. Discriminant and concurrent validity of a simplified DSM-based structured diagnostic instrument for the assessment of autism spectrum disorders in youth and young adults. BMC Psychiatry. 2011 Dec 30; 11:204.
    View in: PubMed
    Score: 0.126
  36. Does ADHD predict substance-use disorders? A 10-year follow-up study of young adults with ADHD. J Am Acad Child Adolesc Psychiatry. 2011 Jun; 50(6):543-53.
    View in: PubMed
    Score: 0.120
  37. Impact of executive function deficits in youth with bipolar I disorder: a controlled study. Psychiatry Res. 2011 Mar 30; 186(1):58-64.
    View in: PubMed
    Score: 0.119
  38. Are stimulants effective in the treatment of executive function deficits? Results from a randomized double blind study of OROS-methylphenidate in adults with ADHD. Eur Neuropsychopharmacol. 2011 Jul; 21(7):508-15.
    View in: PubMed
    Score: 0.119
  39. Do executive function deficits predict later substance use disorders among adolescents and young adults? J Am Acad Child Adolesc Psychiatry. 2011 Feb; 50(2):141-9.
    View in: PubMed
    Score: 0.118
  40. The heavy burden of psychiatric comorbidity in youth with autism spectrum disorders: a large comparative study of a psychiatrically referred population. J Autism Dev Disord. 2010 Nov; 40(11):1361-70.
    View in: PubMed
    Score: 0.116
  41. Cognitive development in adults with attention-deficit/hyperactivity disorder: a controlled study in medication-naive adults across the adult life cycle. J Clin Psychiatry. 2011 Jan; 72(1):11-6.
    View in: PubMed
    Score: 0.116
  42. Child behavior checklist clinical scales discriminate referred youth with autism spectrum disorder: a preliminary study. J Dev Behav Pediatr. 2010 Jul-Aug; 31(6):485-90.
    View in: PubMed
    Score: 0.113
  43. Predictors of ADHD persistence in girls at 5-year follow-up. J Atten Disord. 2011 Apr; 15(3):183-92.
    View in: PubMed
    Score: 0.111
  44. Adult psychiatric outcomes of girls with attention deficit hyperactivity disorder: 11-year follow-up in a longitudinal case-control study. Am J Psychiatry. 2010 Apr; 167(4):409-17.
    View in: PubMed
    Score: 0.110
  45. Are cognitive deficits in attention deficit/hyperactivity disorder related to the course of the disorder? A prospective controlled follow-up study of grown up boys with persistent and remitting course. Psychiatry Res. 2009 Dec 30; 170(2-3):177-82.
    View in: PubMed
    Score: 0.108
  46. Educational and occupational underattainment in adults with attention-deficit/hyperactivity disorder: a controlled study. J Clin Psychiatry. 2008 Aug; 69(8):1217-22.
    View in: PubMed
    Score: 0.099
  47. Effects of stimulant medication on neuropsychological functioning in young adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2008 Jul; 69(7):1150-6.
    View in: PubMed
    Score: 0.099
  48. Temporal stability of ADHD in the high-IQ population: results from the MGH Longitudinal Family Studies of ADHD. J Am Acad Child Adolesc Psychiatry. 2008 Jul; 47(7):817-825.
    View in: PubMed
    Score: 0.099
  49. Stability of executive function deficits in girls with ADHD: a prospective longitudinal followup study into adolescence. Dev Neuropsychol. 2008; 33(1):44-61.
    View in: PubMed
    Score: 0.095
  50. Discordance between psychometric testing and questionnaire-based definitions of executive function deficits in individuals with ADHD. J Atten Disord. 2008 Jul; 12(1):92-102.
    View in: PubMed
    Score: 0.094
  51. Task-induced fatigue and collisions in adult drivers with attention deficit hyperactivity disorder. Traffic Inj Prev. 2007 Sep; 8(3):290-9.
    View in: PubMed
    Score: 0.093
  52. Stability of executive function deficits into young adult years: a prospective longitudinal follow-up study of grown up males with ADHD. Acta Psychiatr Scand. 2007 Aug; 116(2):129-36.
    View in: PubMed
    Score: 0.093
  53. Is attention deficit hyperactivity disorder a valid diagnosis in the presence of high IQ? Results from the MGH Longitudinal Family Studies of ADHD. J Child Psychol Psychiatry. 2007 Jul; 48(7):687-94.
    View in: PubMed
    Score: 0.092
  54. Utility of an abbreviated questionnaire to identify individuals with ADHD at risk for functional impairments. J Psychiatr Res. 2008 Mar; 42(4):304-10.
    View in: PubMed
    Score: 0.090
  55. Can self-reported behavioral scales assess executive function deficits? A controlled study of adults with ADHD. J Nerv Ment Dis. 2007 Mar; 195(3):240-6.
    View in: PubMed
    Score: 0.090
  56. A laboratory driving simulation for assessment of driving behavior in adults with ADHD: a controlled study. Ann Gen Psychiatry. 2007 Jan 30; 6:4.
    View in: PubMed
    Score: 0.089
  57. Impact of psychometrically defined deficits of executive functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry. 2006 Oct; 163(10):1730-8.
    View in: PubMed
    Score: 0.087
  58. A simulated workplace experience for nonmedicated adults with and without ADHD. Psychiatr Serv. 2005 Dec; 56(12):1617-20.
    View in: PubMed
    Score: 0.083
  59. Neuropsychological functioning in youth with bipolar disorder. Biol Psychiatry. 2005 Oct 01; 58(7):540-8.
    View in: PubMed
    Score: 0.082
  60. A Retrospective Chart Review of Buspirone for the Treatment of Anxiety in Psychiatrically Referred Youth with High-Functioning Autism Spectrum Disorder. J Child Adolesc Psychopharmacol. 2019 02; 29(1):28-33.
    View in: PubMed
    Score: 0.051
  61. Further Evidence for Smoking and Substance Use Disorders in Youth With Bipolar Disorder and Comorbid Conduct Disorder. J Clin Psychiatry. 2016 Oct; 77(10):1420-1427.
    View in: PubMed
    Score: 0.044
  62. Dissociation of working memory impairments and attention-deficit/hyperactivity disorder in the brain. Neuroimage Clin. 2016; 10:274-82.
    View in: PubMed
    Score: 0.041
  63. Is psychopharmacologic treatment associated with neuropsychological deficits in bipolar youth? J Clin Psychiatry. 2009 Aug; 70(8):1178-85.
    View in: PubMed
    Score: 0.026
  64. Can bipolar disorder-specific neuropsychological impairments in children be identified? J Consult Clin Psychol. 2007 Apr; 75(2):210-20.
    View in: PubMed
    Score: 0.023
  65. Behavior differences in drivers with attention deficit hyperactivity disorder: the driving behavior questionnaire. Accid Anal Prev. 2005 Nov; 37(6):996-1004.
    View in: PubMed
    Score: 0.020
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.